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B Cells" A Possible Role in T Cell-Independent
B Cell Development
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To identify surface molecules that may play a role in regulating ileal Peyer’s patch (PP) B
cell growth, we generated monoclonal antibodies (mAbs) and then selected them for a
unique reactivity with ileal PP B cells. Flow cytometric analysis identified amAb (SIC4.8R)
that labeled 97% of ileal and 50-60% of jejunal PP sIgM/B cells. SIC4.8R also labeled a
subpopulation of cortical thymocytes but few B or T cells in other lymphoid tissues, in-
cluding bone marrow. Immunohistochemistry revealed intense SIC4.8R staining of B cells
in the cortex of ileal PP follicles. SIC4.8R also labeled bovine PP B cells, a murine pro-B
cell line, and pre-B cells in human bone marrow. Protein chemistry revealed that a struc-
turally similar molecular complex was expressed on sheep ileal PP B cells and thymocytes
and murine pro-B cells. Addition of soluble SIC4.8R to cultured ileal PP B cells reduced
apoptotic cell death, elevated proliferative responses, partially inhibited anti-Ig-induced
cell death, and induced IL-4 responsiveness. In contrast, soluble SIC4.8R had an anti-
proliferative effect on a mouse pro-B cell line. Finally, SIC4.8R labeling declined following
the stimulation of ileal PP B cells with CD40 ligand. In conclusion, the present investiga-
tion determined that SIC4.8R identified a novel molecular complex that is expressed at
several stages of T cell-independent B cell development in a variety of mammalian species.
This observation confirmed that PP B cells are developmentally distinct from other
B cell populations in sheep and suggested that the bone marrow may not be a site of B
lymphopoiesis in young lambs.
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INTRODUCTION
For many mammalian species, the gut-associated
lymphoid tissues, including Peyer’s patches (PP),
provide an unique and essential environment for
B cell development (Cooper and Lawton, 1972;
Chapman et al., 1974; Reynolds and Morris, 1983).
This is evident for the ileal PP of sheep, which
functions as a primary lymphoid tissue for B cell
development with antigen-independent and T cell-
independent diversification of the Ig receptor
repertoire (Reynaud et al., 1995). Furthermore,
*Corresponding author: Present address: Veterinary Infectious
Disease Organization, University of Saskatchewan, 120-
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numerous in vivo and in vitro investigations have re-
vealed that B cells present within lymphoid follicles
of the ileal PP (iPfB cells) of sheep are develop-
mentally and phenotypically distinct from B cells in
other lymphoid tissues (Reynolds, 1986; Hein et al.,
1989; Griebel et al., 1991, 1992a).
B cell production in the ileal PP begins during fetal
development and continues at approximately the
same rate until lambs reach sexual maturity
(Reynolds, 1987). During this time, the mitotic in-
dex within ileal PP lymphoid follices is four to five
times greater than that of the thymus. However,
approximately 95% of the iPfB cells produced then
die by apoptosis, which suggests that B cell deve-
lopment is closely regulated by a number of soluble
factors or cell-cell interactions. (Reynolds, 1986;
6768 GRIEBEL et al.
Motyka and Reynolds, 1991). The proliferation of
iPfB cells can be inhibited by either anti-Ig treatment
in vitro (Griebel et al., 1991) or corticosteroid treat-
ment in vivo (Griebel et al., 1996). Furthermore, iPfB-
cell proliferation can be sustained in culture by a
direct B cell-stromal cell interaction (Griebel and
Ferrari, 1994) but not an interaction with CD40
ligand (Griebel and Ferrari, 1995). Thus, B cell
production in the ileal PP appears to be T cell-
independent and may be sustained by a variety of B
cell-stromal cell interactions (Griebel et al., 1993).
Previous investigations revealed that many sur-
face molecules present on mature B cells of sheep
were absent from the immature iPfB cells (Hein
et al., 1989; Griebel et al., 1992b). Therefore, we hy-
pothesized that the unique physiology and function
of B cells in the ileal PP would be reflected in the
expression of a distinctive array of surface molecules.
Furthermore, we postulated that some of these mol-
ecules may be involved in regulating iPfB cell pro-
liferation and differentiation. To test this hypothesis,
we generated a panel of monoclonal antibodies
(mAbs) that were screened for a specific reactivity
with iPfB cells. One such mAb was identified and
then tested in vitro to determine if it identified a
molecule that could transduce a signal(s) that influ-
enced iPfB cell growth.
RESULTS
Selection of iPfB Cell-Specific
Monoclonal Antibodies
A total of 186 hybridomas were screened with flow
cytometry and 16 mAbs were identified that reacted
with iPfB cells but not PBM cells. IHC revealed that
12 of the mAbs selected reacted with antigens that
were also present in mesenchymal cells or mucosal
epithelial cells. One mAb (SIC4.SR; IgM isotype)
reacted with a surface molecule that was expressed
at a high level on most sIgM iPfB cells (Fig. la; Table
1), but a minor subpopulation (<10%) of B cells in
blood (Fig. lc; Table 1). SIC4.SR also labeled a sub-
population of sIgM B cells in jejunal PP follicles
(Fig. lb; Table 1) and minor B cell subpopulations in
the MLN and efferent lymph from the prescapular
lymph node (Table 1). SIC4.SR reactivity was not
restricted to the B cell lineage, but also included a
subpopulation of blood T cells (Fig. lg) and cortical
CD5) thymocytes (Fig. lh). IHC staining of lamb
tissues with SIC4.SR revealed that lymphocyte clus-
ters in the cortex of ileal PP follicles expressed a high
level of antigen (Figs 2A and B). In contrast, intense
staining by SIC4.SR was observed for most lym-
phocytes within the follicles of fetal jejunal and ileal
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FIGURE 1. SIC4.8R labels most sIgM B cells in ileal PP follicles, a subpopulation of sIgM B cells in jejunal PP follicles but few
sIgM B cells from the blood (PBM cells) of young lambs. SIC4.8R also labeled a minor subpopulation of T cells (CD5/) in all
lymphoid tissues examined, including the thymus (CD5).MOLECULAR COMPLEX EXPRESSED ON IMMATURE LYMPHOCYTES 69
PP (data not shown). This was consistent with the
flow cytometric data, which revealed that most
sIgM B cells in the ileal and jejunal PP of a 144-day
fetus (Figs. 3a and b) were labeled at a high level.
Few T cells in the fetal PP were labeled (Figs 3e and
f), but some T cells in blood and thymus were labeled
(Figs 3g and h). These analyses indicated that
SIC4.8R identified a molecule expressed on imma-
ture lymphocytes of both the B (iPfB cells) and T
cell (cortical thymocytes; CD5l) lineage, but not
lymphoid, myeloid, or erythroid lineages in the bone
marrow (Figs 4a and b).
Cross-Species Reactivity of SIC4.8R
Monoclonal Antibody
To further characterize the specificity of the SIC4.8R
mAb, its reactivity with leukocytes from a variety of
species was analyzed. A strong reaction was ob-
served with B cells isolated from the ileal and jejunal
PP, but not PBM cells of young calves (data not
shown). This indicated that the pattern of SIC4.8R
labeling was conserved among ruminants. A more
remarkable conservation was suggested by SIC4.8R
labeling of a murine pro-B cell line (Fig. 4d). This
RAG-2 gene-deleted pro-B-cell line was chosen be-
cause it did not express endogenous IgM (Fig. 4e).
Furthermore, co-staining for SIC4.8R and a number
of pro-B-cell surface molecules, including heat-sta-
ble antigen (HSA; Figs 4e ahd f), CD25, CD43, and
IL-7 receptor, revealed that the SIC4.8R molecule was
FIGURE 2. SIC4.8R specifically stained lymphocytes in
lymphoid follicles of the ileal PP of a lamb. (A) Immu-
noperoxidase staining was most intense in the cortex of the
follicles (f) with no visible staining in the dome (d) region.
Magnification: x25. (B) High magnification (x250) of the ileal PP
follicle (f) clearly shows that clusters of cells adjacent to the follice
capsule (c) stain intensely with SIC4.8R.
TABLE
Labeling of T and B lymphocytes Populations by SIC4.8R
Percent positive cells
Cell Total sIGM sIgM CD5 CD5
population SIC4.8R SIC4.8R SIC4.8R- SIC4.8R SIC4.8R-
Ileal ppb 96.6 + 1.3 94.6 + 1.8 2.8 + 0.6 0.04 + 0.02 0.22 + 0.05
Jejunal ppb 47.2 + 3.4 27.2 + 2.9 26.8 + 2.4 1.5 + 0.3 9.9 + 1.1
MLN 14.5 + 2.3 8.8 + 1.2 21.0 + 2.9 7.5 + 2.2 59.1 + 3.4
PBM Cells 9.2 + 2.7 4.8 + 0.6 44.3 + 4.1 3.5 + 0.4 38.4 + 2.8
Eff. Lymph 8.8 + 0.9 1.4 + 0.6 13.3 + 1.8 6.8 + 1.8 78.4 + 3.8
Bone marrow 4.3 + 1.1 2.1 + 0.7 32.5 + 4.4 1.8 + 0.6 34.1 + 3.7
Thymocytes 22.4 + 6.2 0.05 + 0.03 0.6 + 0.2 21.4 + 7.4 77.0 + 6.9
aData presented the S.D. of values for cells isolated from 4, 6-10-week-old lambs.
bCell suspensions prepared from PP lymphoid follicles.
cMLN: mesenteric lymph node.
dPBM: peripheral blood mononuclear cells.
eLymph draining the prescapular lymph nodes of 1-2-year-old sheep.
fTotal SIC4.8R cells included analysis of erythroid, myeloid, and lymphoid populations in bone cells.70 GRIEBEL et al.
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FIGURE 3. SIC4.8R labels most sIgM/B cells in fetal ileal and jejunal PP follicles but subpopulations of sIgM SIC4.8R/B cells were
also evident. Few sIgM/B cells from the blood (PBM cells) were labeled but a subpopulation of T cells (CD5/) in fetal blood and
thymus (CD5) were SIC4.8R/.
distinct from these known pro-B-cell surface mol-
ecules. Further conservation of the SIC4.8R molecule
was suggested by the specific labeling of human
CD10/CD19 pre-B cells but not mature B cells in
bone marrow or blood (Table 2). However, SIC4.8R
reactivity also included a minor subpopulation of
NK cells (Table 2). Finally, conservation of the
SIC4.8R reactivity did not extend to chickens because
neither bursal B cells or blood leukocytes were
labeled by this mAb (data not shown).
Protein Chemistry of the SIC4.8R
Molecular Complex
The extensive cross-species activity of SIC4.8RmAb
suggested that either a single epitope was highly
conserved or that a fortuitous cross-reactivity oc-
curred among distinct molecules. Protein chemistry
was used to determine if a structurally similar pro-
tein was identified by SIC4.8R on both sheep and
mouse cells. The SIC4.8R mAb precipitated a mo-
lecular complex from sheep iPfB cells that consisted
of multiple proteins that were visible under reduc-
ing conditions (Fig. 5). Following iPfB cell lysis with
Brij, the SIC4.8R mAb specifically precipitated sev-
eral proteins but the three bands indicated at 53, 55,
and 75 kD (Fig. 5, lanes 1 and 2; reduced) were the
only proteins observed following lysis with NP-40
TABLE 2
SIC4.8R Labeling of Lymphocyte Subpopulations from
Human Bone Marrow and Blood
Percent positive cells
Bone
Cell population marrow PBM cells
Progenitor B cells <5 N.D.
(CD10/, CD19/, CD34/, TdT/)
Precursor B cells 60-75 N.D.
(CD10+, CD19/, Cyto%t+)
Immature B cells <5 N.D.
(CD10/, CD19/, sIgM+, sIgD-)
Mature B cells <0.1 <0.1
(CD10-, CD19/, sIgM/, sIgD/)
T cells <0.1 <0.1
(z[ T cells <0.1 <0.1
NK-cells
(CD2/, CD56/) 5-10 6-10
SIC4.8R cells expressed percentage of each subpopulation. Data presented
the range of values.
bBone biopsies from 4, 3-11-year-old children.
Blood collected from clinically normal individuals 18 years of age.
dN.D.: not determined.
and digitonin (data not shown). Three proteins of
similar molecular weight were seen with lysates of
sheep thymocytes but the 75-kD band often gave
a much stronger signal than the 53- and 55-kD
proteins (data not shown). SIC4.8R also precip-
itated a multimeric protein complex from surface-MOLECULAR COMPLEX EXPRESSED ON IMMATURE LYMPHOCYTES 71
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FIGURE 4. SIC4.8R labeling of lymphoid cells in the bone marrow of a lamb revealed few positive cells among the sIgM B cells
(a), CD5 T cells (b), or other lymphoid-lineage cells. The lymphoid (R1; 6.3% nucleated cells), erythroid (R2; 27.9% nucleated cells),
and myeloid (R3; 24.0% nucleated cells) bone marrow cells were analyzed but no SIC4.8R cells were detected in either R2 or R3.
In contrast, a pro-B cell line, established from a RAG-2 gene-deleted/bcl-2 transgenic mouse, labeled strongly with SIC4.8R (d) but
not SIC7.3b, an isotype-matched mAb (c). Co-labeling of mouse pro-B cells with anti-HSA and SIC4.8R indicated that these were
distinct molecules (f).
biotinylated, Brij-lysed mouse pro-B cells (Fig. 5; lane
6). This complex consisted of at least three proteins
with clearly visible bands at 53, 55, and 75 kD. A
number of other bands appeared to be specific but
were faintly visible and were not seen when NP-40
or digitonin were used for cell lysis (data not shown).
In conclusion, protein chemistry clearly showed that
the SIC4.8RmAb reacted with a multimeric complex
on both sheep iPfB cells and mouse pro-B cells. The
number of proteins in this complex varied with the
detergent used for cell lysis, which suggests that this
complex included non covalently linked proteins.
This was most evident with sheep iPfB cells where
a greater number of proteins were precipitated fol-
lowing Brij lysis and some of these bands were simi-
lar in size to proteins that were precipitated by an
anti-IgM reagent (Fig. 5: lanes 1 and 3; reduced).
B Cell Growth Is Altered by Soluble
SIC4.8R Monoclonal Antibody
To determine if the SIC4.8R molecular complex could
function to regulate B cell growth, we assayed the
effects of soluble mAb on cultured iPfB cells. IPfB
cells rapidly undergo apoptotic cell death during
culture (Motyka and Reynolds, 1991) and this72 GRIEBEL et al.
FIGURE 5. Immunoprecipitation of biotinylated surface proteins from sheep iPfB cells and a mouse pro-B cell line, following lysis
with Brij, revealed that SIC4.8R reacted with a multimeric protein complex, iPfB cells, non-reduced: Lane 1: Lysate from 5 x 106 iPfB
cells reacted with SIC4.8R; lane 2: Lysate from 2 x 10 iPfB cells reacted with SIC4.8R; lane 3: Lysate from 5 x 10 iPfB cells reacted
with SIC7.3b (IgM isotype control). No specific proteins were visible under nonreducing conditions, iPfB cells, reduced: Lane 1:
Lysate from 5 x 10 iPfB cells reacted with SIC4.8R. Numerous specific bands were visible and bands at 52, 55, and 75 kD are
indicated (>) because these bands were also visible in lane 2 where lysate from 2 x 106 iPfB cells was reacted with SIC4.8R. Lane
3: Lysate from 5 x 106 cells reacted with rabbit anti-sheep IgM revealed a heterogeneous Ig heavy chain (80 kD; _1_), Ig light chain
(28 kD; _1_), and at least 2 other Ig-associated proteins between 30-50 kD. Lane 4: Lysate from 5 x 106 iPfB cells reacted with the
SIC7.3b mAb (IgM isotype control). Mouse pro-B cells, non-reduced: Lane 1: Lysate from 5 x 106 pro-B cells reacted with SIC7.3b
mAb (IgM isotype control). Lane 2: Lysate from 2 x 106 pro-B cells reacted with SIC4.8R, Lane 3: Lysate from 5 x 106 pro-B cells
reacted with SIC4.8R, No specific bands were visible under nonreducing conditions. Mouse pro-B cells, reduced: Lane 4: Lysate
from 5 x 106 pro-B cells reacted with SIC7.3b mAb (IgM isotype control). Lane 5: Lysate from 2 x 106 pro-B cells reacted with SIC4.8R.
Specific protein bands were visible at 52 and 55 kD (<). Lane 6: Lysate from 5 x 10 reacted with SIC4.8R. A third protein band was
then visible at 75 kD (<) with faint shadows between 60-60 kD and below 30 kD.
apoptotic cell death can be quantitated by a flow
cytometric analysis of PI incorporation and FALS
(Griebel and Ferrari, 1995). Following a 24-hr incu-
bation with 10 tg/ml of the purified, irrelevant
SIC7.3b mAb (IgM isotype), less than 35% of iPfB
cells remained viable and many cells were PI+FALS
(Fig. 6a). A 24-hr co-culture with mCD40L/J558L
cells was included as a positive control to demon-
strate a clear reduction in iPfB cell apoptotic cell
death (Fig. 6b; Griebel and Ferrari, 1995). Following
a 24-hr incubation with 10 tg/ml of purified SIC4.8R
mAb, there was a two-fold increase in viable iPfB
cell number that correlated with a marked reduc-
tion in the percentage of PI/FALS1 cells (Fig. 6c).
Thus, soluble SIC4.8R acted as a ligand that induced
a signal(s) that blocked apoptotic cell death and
supported an increased level of iPfB cell prolifera-
tion (Fig. 7a).
Previous investigations determined that ligating
surface (s)IgM on iPfB cells with soluble antibody
(anti-Ig) resulted in cell death (Griebel et al., 1991).
However, anti-Ig activity was inhibited by either
CD40 co-signaling (Griebel and Ferrari, 1995) or an
interaction between stromal cells and iPfB cells
(Griebel and Ferrari, 1994). Therefore, we investi-
gated the possibility that co-signaling by the SIC4.8
complex would also alter the effect of anti-Ig on iPfB
cells. The addition of soluble SIC4.8RmAb reduced
the anti-mitotic effect of anti-Ig, and with the ad-
dition of both IL-4 and soluble SIC4.8R mAb, the
inhibitory activity of anti-Ig was reduced by approxi-
mately 50% (Fig. 7a). Therefore, mAb binding to theMOLECULAR COMPLEX EXPRESSED ON IMMATURE LYMPHOCYTES 73
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FIGURE 6. Soluble SIC4.8R inhibits iPfB cell apoptotic cell death
(A) IPfB cells cultured for 24 hr in medium (control; 10 tg/ml
SIC7.3b mAb) undergo extensive cell death by apoptosis (PI
FALSI) with few viable cells surviving in culture (31.7% PI-
FaLShi). (B) Co-culture with mCD40L/J558L cells for 24-hr re-
duced iPfB-cell apoptotic cell death and increased cell viability
(53.5% PI- FALS"i). (C) The addition of 10 g/ml soluble SIC4.8R
for 24-hr reduced iPfB-cell apoptotic cell death and doubled cell
viability (60.3% PI- FALShi) relative to the control culture.
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FIGURE 7. Soluble SIC4.8R altered the proliferative responses
of both iPfB cells and murine pro-B cells. (a) SIC4.8R (4.8R) in-
duced an iPfB cell proliferative response that was not observed
with an isotype-matched mouse mAb (7.3b). F(ab’) rabbit anti-
sheep IgM (anti-Ig + medium)-inhibited iPfB cell proliferative
responses but the addition of soluble SIC4.8R (anti-Ig + 4.8R)
reduced the level of anti-Ig inhibition. The addition of both
IL-4 and SIC4.8R (anti-Ig + 4.8R + IL) reduced the anti-mitotic
activity of anti-Ig by approximately 50%. Proliferative responses
were assayed with 4 x 105 iPfB cells/well and [HB]-thymidine
was added 4 hr prior to harvesting the 48-hr culture. (b) SIC4.8R
specifically induced IL-4 responsiveness but no response was
observed with other IL-2 receptor, T-chain-common family
cytokines, including IL-2, IL-7, and IL-15. No increase in iPfB
cell proliferative responses was induced by the cytokines in the
absence of SIC4.8R. Proliferative responses were assayed with 4
x 105 iPfB cells/well and [HS]-thymidine was added 4 hr prior to
harvesting the 48-hr culture. (c) Soluble SIC4.8R inhibited the
proliferation of the IL-7-dependent and stromal cell-dependent
mouse pro-B cell line. This anti-mitotic activity was dose-depend-
ent, requiring 10 tg/ml purified mAb to effect maximal inhibi-
tion (>90%). Proliferative responses were assayed with 5 x 104
pro-B cells and x 104 T-irradiated PA-6 cells/well and 10 ng/ml
recombinant human IL-7. The [HB]-thymidine was added 4 hr
prior to terminating the 24-hr culture.74 GRIEBEL et al.
SIC4.8R complex induced a signal(s) in iPfB cells that
partially inhibited the cell death induced by cross-
linking sIgM. Significant, IL-4 activity in this assay
was only observed when iPfB cells were co-
stimulated with SIC4.8R and further assays con-
firmed that soluble SIC4.8R mAb specifically
induced IL-4-responsiveness but not responsive-
ness to several other 7-chain-common cytokines
(Fig. 7b).
Finally, the functional activity of the SIC4.8R com-
plex was investigated with the RAG2 gene-deleted/
bcl-2 transgenic mouse pro-B cell line during co-
culture with PA-6 stromal cells and in the presence
of IL-7. We observed a clear dose-dependent inhi-
bition of pro-B cell growth with soluble, purified
SIC4.8R mAb (Fig. 7c). At concentrations exceeding
10 gg/ml, the SIC4.8R inhibited 90% of pro-B cell
proliferation.A similar inhibition was also observed
when pro-B cells were pre-incubated with SIC4.8R
mAb prior to co-culture but did not occur when the
PA-6 stromal cells were pre-incubated with themAb
(data not shown). For these experiments, the cells
were washed three times with culture medium fol-
lowing pre-incubation with the mAb. In contrast, a
purified, isotype-matched antibody, SIC7.3b mAb,
did not alter the proliferative response of pro-B cell
cultures (data not shown). Thus, SIC4.8R binding to
pro-B cells resulted in a strong anti-proliferative
effect. The pro-B-cell line was derived from a bcl-2
transgenic animal and in the presence of SIC4.8R
mAb, no cell death was observed and viable pro-B
cell number remained constant (data not shown).
IPfB Cell Differentiation Downregulates
Expression of the SIC4.8R Complex
SIC4.8R labeling of mouse pro-B cells, human pre-B
cells, sheep cortical thymocytes, and iPfB cells sug-
gested that this molecular complex was expressed
by early precursor and immature lymphocytes.
Therefore, we investigated whether a signal, such
as CD40 ligand, which induces iPfB cell differentia-
tion (Griebel and Ferrari, 1995), would alter expres-
sion of the SIC4.8R complex. SIC4.8R labeling was
analyzed at 48-hr intervals following iPfB cell
co-culture with mCD40L/J558L cells. During this
co-culture, there was a progressive decrease in the
level of SIC4.8R labeling such that after 96 hr, little
detectable labeling remained (Fig. 8). Thus, CD40
signaling, which is associated with T cell-depend-
ent B cell development, downregulated the expres-
sion of the SIC4.8R molecular complex on iPfB cells.
Previous work clearly demonstrated that CD40
signaling inhibited iPfB cell death and supported a
limited degree of cell-proliferation and differentia-
tion (Fig. 6B; Griebel and Ferrari, 1995). Thus, it was
unlikely that the decrease in SIC4.8R labeling re-
sulted from the outgrowth of a minor subpopulation
of sIgM+SIC4.8R B cells.
DISCUSSION
Previous investigations of surface molecules ex-
pressed by sheep PP B cells used antibodies that
reacted with lymphocytes in blood and other non-
PP lymphoid tissues (Hein et al., 1989; Griebel et al.,
1992a, 1992b). The present investigation took a very
different approach by first selecting mAbs with a
reactivity unique to PP B cells. This resulted in the
selection of the SIC4.8R mAb (Fig. 1; Table 1) that
displayed a remarkable cross-reactivity with a simi-
lar molecular complex on a murine pro-B cell line
(Figs 4 and 5) and also reacted with human pre-B
cells (Table 2). The lack of SIC4.8R reactivity with
sIgM B cells isolated from several lymphoid tissues
of sheep (Table 1) and blood and bone marrow of
humans (Table 2) clearly indicated that the molecu-
lar complex identified was distinct from molecules
known to be expressed on mature, sIgM B cells. Co-
staining of a RAG2 gene-deleted/bcl-2 transgenic
mouse pro-B cell line with SIC4.8R mAb and anti-
bodies for several known pro-B cell molecules pro-
vided further evidence that a novel molecular
complex had been identified (Fig. 4; data not pre-
sented). Protein chemistry confirmed that the
SIC4.8R mAb identified a structurally similar mo-
lecular complex on both Sheep and murine B cells
(Fig. 5) and a review of known CD molecules did
not reveal any B cell molecules with a similar struc-
ture or pattern of expression (Barclay et al., 1993).
Thus, the selection method used to identify the
SIC4.8R mAb was an effective means to detect sur-
face molecules unique to the immature B cells pre-
sent in sheep PP (Figs 1, 3, and 4).
The second objective of this investigation was to
identify molecules that may function to regulate the
development ofPP B cells. Evidence that the SIC4.8R
complex may influence iPfB cell development was
provided by a number of in vitro assays with solu-
ble, purified mAb (Figs 6 and 7). These assays con-
firmed that the SIC4.8R complex could transduce a
signal(s) that altered iPfB cell survival and proli-
feration, co-signaling by sIgM, and induce cytokineMOLECULAR COMPLEX EXPRESSED ON IMMATURE LYMPHOCYTES 75
responsiveness. The multiplicity of effects observed
with soluble SIC4.8R mAb may have several expla-
nations. This protein complexmay utilize a signaling
pathway that is shared by many other surface mol-
ecules. Alternatively, as suggested by the protein
chemistry (Fig. 5), this molecular complex may as-
sociate with other proteins that possess co-signaling
functions that can influence iPfB cell development.
IPfB cell responses to the SIC4.8R mAb also raised
questions regarding a possible ligand(s) for the
SIC4.8R complex. It was thought that the well-
defined growth requirements of the mouse pro-B cell
line might provide a better system to investigate
this question (Grawunder et al., in press). The anti-
mitotic activity of soluble SIC4.8R mAb suggested
that this mAb may block an essential interaction
between pro-B cells and a molecule expressed on
PA-6 stromal cells (Fig. 7c). However, it may actu-
ally be the absence of a ligand for the SIC4.8R
complex on PA-6 cells that permits the long-term cul-
ture of mouse pro-B cells. In conclusion, the in vitro
activity of soluble SIC4.8R mAb confirmed that this
molecular complex could influence iPfB cell growth
by modulating a variety of B cell responses. How-
ever, the present experiments provided no clues
regarding the nature of a relevant ligand(s) for the
SIC4.8R complex.
Expression of the SIC4.8R complex on precursor
and immature lymphocyte populations raises fur-
ther questions regarding possible developmental
similarities among these different cell populations.
The disparate responses of iPfB cells and the murine
pro-B cell line to SIC4.8RmAb may indicate that this
molecular complex performs different functions
during different stages of B cell development. How-
ever, these results are preliminary and the transgenic
murine pro-B cell line may not reflect normal physi-
ological responses. One possible developmental
similarity among mouse and human precursor B
cells and iPfB cells may be that all these B cell devel-
opment stages are stromal cell-dependent and T cell-
independent (reviewed in Rolink and Melchers,
!993; Griebel and Ferrari, 1994). Previous investiga-
tions revealed that T cell-dependent B cell develop-
ment predominates in the jejunal PP of lambs but
plays a minor role in ileal PP B cell development
(Hein et al., 1989; Griebel and Ferrari, 1995). Thus,
the postnatal decline in SIC4.8R expression on jejunal
PP B cells and the CD40L-induced downregulation
of the SIC4.8R complex (Fig. 8) support the conclu-
sion that the SIC4.8R complex 1nay play a role dur-
ing T cell-independent B cell development. If this
Fresh iPfB cells
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FIGURE 8. Co-culture of iPfB cells with mCD40L/J558L cells
downregulated SIC4.8R expression. (a) Freshly isolated sIgM
iPfB cells labeled with SIC4.8R. (b) After a 48-hr co-culture with
mCD40L/J558L cells, fewer than 40% sIgM iPfB cells labeled
with SIC4.8R. (c) Following a 96-hr co-incubation withmCD40L/
J558L cells, fewer than 10% sIgM iPfB cells labeled with SIC4.8R.
All phenotypic analyses were restricted to viable cells (PI- FALSh’),
and viable iPfB cell number remained relatively constant
throughout the 96-hr culture period. The percent SIC4.8R sIgM
B cells is indicated in quadrant 2 of each profile.
conclusion is valid, then SIC4.8R labeling may
reveal that T cell-independent B cell development
occurs in all fetal PP but this pathway of B cell
development declines in the jejunal PP of lambs
(Figs I and 3). Furthermore, the absence of SIC4.8R
lymphoid cells in bone marrow (Fig. 4) may reveal
that this is not an active site for B lymphopoiesis in76 GRIEBEL et al.
young lambs. There is presently no direct evidence
that the SIC4.8R complex is conserved on sheep pre-
B cells but investigations are now in progress to
further characterize the population of sIgM-SIC4.8R
cells observed in the fetal PP (Figs 3a and b). If these
cells are indeed pre-B cells, then this may provide
substantial evidence that sheep possess a pathway
of B cell development in the PP that is distinct from
that defined for rodents (reviewed in Rolink and
Melchers, 1993).
Identification of the SIC4.8R complex provided
further evidence that the B cell population present
in sheep PP is distinct from B cells in other lymphoid
tissues and provided further insights into the devel-
opmental biology of sheep PP B cells. Conservation
of the SIC4.8R protein complex on precursor and
immature lymphocytes of both the T and B cell lin-
eage in several mammalian species suggests that this
molecular complex may play an important role or
roles in regulating lymphopoiesis. The in vitro as-
says with soluble SIC4.8RmAb clearly demonstrated
that this molecular complex can transduce signals
that influenced iPfB cell and mouse pro-B cell growth
and survival. Therefore, further characterization of
the structure and function of this complex should
provide significant insights into the regulation of
mammalian lymphocyte development.
MATERIALS AND METHODS
Generating and Selecting Hybridomas
BALB/c mice were injected intraperitoneally, 3 times
at monthly intervals, with iPfB cells isolated from
6-8-week-old lambs. Three days after the last injec-
tion of iPfB cells, the splenocytes were fused with
Sp 2/0 myeloma cells using standard procedures.
Hybridomas were then screened for reactivity with
sheep iPfB cells, but no reactivity with peripheral
blood mononuclear (PBM) cells using a protocol
described by Davis et al. (1995). Briefly, PBM cells
were prelabeled with hydroethidine (Polysciences,
Warrington, PA) and then mixed 1:1 with iPfB cells.
Thus, during flow cytometric analyses, thePBM cells
could be distinguished from iPfB cells by their fluo-
rescence in FL2. An aliquot of the PBM cell and
iPfB cell mixture was then incubated with culture
supernatant from each hybridoma, washed three
times with phosphate-buffered saline (PBS), and
reacted with FITC-goat anti-mouse Ig (Southern
Biotechnology Associates, Birmingham, AL). Sam-
ples were analyzed with a FACScan flow cytometer
(Becton-Dickinson, Mountain View, CA) and mAbs
that reacted with iPfB cells but not PBM cells were
further screened in an immunohistochemical (IHC)
stain of cryosections prepared from ileal PP, jejunal
PP, thymus, and mesenteric lymph node (MLN). All
clones selected by flow cytometric analysis were
subcloned by limiting, dilution and a second sub-
cloning was performed following selection by
immunohistochemistry.
Isolation of Lymphoid Cells
All experiments were conducted using 6-10-week-
old suckling lambs or 142-144-day gestation fetuses
(term 150-day gestation) of either sex from
Versuchbetrieb Sennweid (Olsburg, Switzerland).
Blood was collected in EDTA and PBM cells were
isolated with a discontinuous Percoll gradient,
as described previously (Dudler et al., in press).
Single-cell suspensions for mouse immunizations,
flow cytometry, and cultures were prepared from
lymphoid follicles of the ileal and jejunalPP of lambs,
fetuses, and 1-2-week-old calves, as described pre-
viously (Griebel, in press). Single-cell suspensions
were prepared from thymus and MLN by mincing
tissues in PBS and then filtering the cell suspension
through a 20-tm nylon mesh (Small Parts, Miami,
FL). Bone marrow cells were isolated from the ster-
num of lambs, as described previously (Haig, in
press). Heparinized samples of human bone mar-
row were obtained by iliac crest aspiration, follow-
ing institutional guidelines of the Basel Kantonspital
and Kinderspital of Basel. Bone marrow aspirates
were from 4 children, two boys and two girls be-
tween 3 and 11 years of age, who were determined
to be healthy and free of hematological diseases.
Human blood was obtained from 3 clinically nor-
mal donors and the buffy coat collected. Human
bone marrow cells and PBM cells were isolated by
centrifugation over a Ficoll-Hypaque density gradi-
ent (1.077 g/ml; Pharmacia, Uppsala, Sweden).
Flow Cytometry and Immunohistochemistry
All analyses were conducted with either a FACScan,
FACStar Plus, or FACSVantage (Becton-Dickinson).
Indirect immunofluorescence of single- or dual-
labeled sheep cells was completed with uncon-
jugated mAbs that were detected with isotype-
specific, FITC-, or PE-conjugated goat anti-mouse Ig
(Southern Biotechnology), as described previously
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mAb (PIg45A) was purchased from VMRD (Pull-
man, WA) and the anti-sheep CD5 mAb (STla) was
produced from a hybridoma maintained at the Basel
Institute for Immunology. The anti-mouse heat-
stable antigen (HSA; J11d), anti-mouse CD25 (7D4),
and anti-mouse CD43 ($7) were purchased from
Pharmingen (San Diego). The anti-mouse IL-7 re-
ceptor mAb (Sudo, et al., 1993) was a generous gift
from S.I. Nishikawa (Kumamoto University School
of Medicine, Kumamoto, Japan). Flow cytometric
analysis of surface molecules onhuman lymphocytes
was done by direct and indirect immunofluorescence
using the following mAbs: FITC-anti-CD2; FITC-
anti-CD3; PE- and biotinylated anti-C4; FITC-anti-
CD7; biotinylated anti-CD8; biotinylated anti-CD10;
biotinylated anti-CD19; FITC-anti-CD20; PE-anti-
CD33; FITC- and PE-anti-CD34; FITC-anti-CD56;
and FITC-anti-,3 TcR (Becton-Dickinson). The FITC-
anti-0 TcR mAb was purchased from T Cell Diag-
nostics (Cambridge, MA). The FITC-conjugated,
F(ab’) rabbit anti-human IgM was purchased
from Dakopatts (Glostrup, Denmark) and the
PE-conjugated goat anti-mouse IgM and PE- and
TRI-streptavidin were purchased from Southern
Biotechnology. The bone marrow cells were main-
tained at4C during the labeling procedure and were
analyzed within 4 hr of aspiration. All flow cyto-
metric analyses were restricted to viable cells by
adding 2 tg/ml propidium iodide (PI; Calbiochem-
Behring, La Jolla, CA) to each sample and excluding
all positive cells in FL3. Id6ntification of apoptotic
and viable ileal PP B cells was based on an analysis
of both PI staining and forward angle light scatter
(FALS; Griebel and Ferrari, 1995). The preparation
of sheep tissues for cryosections and the indirect
immunoperoxidase method to detect mAb binding
in tissue sections were as previously described in
detail (Griebel et al., 1996).
Protein Chemistry
Freshly isolated ileal PP cells or cultured murine pro-
B cells were washed three times with PBS and then
surface biotinylated with 0.2 mg/ml Sulfo-NHS-
biotin (Pierce Chemical, Rockford, IL). After 20-30
min, the reaction was quenched with 25 mM lysine
and cells were lysed in either NP-40 (0.5%; Sigma,
St Louis, MO), digitonin (1%; Sigma), or Brij 97 (1%;
Sigma). The lysis buffer contained a mixture of
protease inhibitors that included leupeptin, apro-
tinin, amino-caproic acid, and p-aminobenzamidine
(Sigma). The lysate was precleared by incubating for
2 hr with 40 tl of Seph-CNBr-goat-anti-mouse Ig
beads (Pharmacia). The lysate was then reacted for
2 hr with 20 tg ofmAb and the immunoprecipitation
performed with Seph-CNBr beads conjugated with
either goat-anti-mouse Ig (Cappel) or goat anti-
mouse IgM (Southern Biotechnology). After 3
washes, the beads were boiled in Laemli sample
buffer (+DTT) before running on a discontinuous
SDS-PAGE. Proteins were transferred by semidry
blot onto Immobilon PVDF (Millipore) and the fil-
ter was then blocked with nonfat dry milk (5% in
PBS with 0.1% Tween-20). The filter was washed,
reacted with Strep-HRPO (1:5000; Southern Biotech-
nology), and then developed with ECL Detection
reagents (Amersham, Buckinghamshire, UK) and
Hyperfilm-ECL (Amersham).
Cell Lines
A murine pro-B cell line, carrying all Ig genes in
germline configuration, was established from the
fetal liver of a RAG-2 gene-deleted/bcl-2 transgenic
mouse (Grawunder et al., in press). The sustained
growth of this cell line was dependent on contact
with PA-6 stromal cells and exogenous IL-7. J558L
cells were transfected with a plasmid expressing the
mouse CD40L gene, and L-Histidinol (Sigma) was
used to select a clone that expressed high levels of
membrane CD40L (mCD40L; Peter Lane, Basel In-
stitute for Immunology). Prior to co-culture, the
mCD40L/J558L cells were 7-irradiated (9000 rads)
to inhibit cell growth. This irradiation did not re-
duce mCD40L expression and mCD40L was pre-
viously shown to interact specifically with CD40
expressed on iPfB cells (Griebel and Ferrari, 1995).
Cell Cultures
All cultures were incubated at 37C in a humidified
atmosphere with 7% CO in air. The culture medium
was Iscove’s modified Dulbecco’s modified Eagle
medium (Gibco/BRL, Basel) supplemented as pre-
viously described (Griebel et al., 1993) plus 2% FBS
(Gibco/BRL). Cultures for the analysis of viable cell
number and cell phenotype were conducted in
6-well plates (Nunc, Roskilde, Denmark) and pro-
liferative response assays were conducted in flat-
bottom, 96-well plates (Nunc). Investigations of
SIC4.8R and SIC7.3b (IgM isotype) activity with
cultured cells were conducted with ammonium-
sulfate-purified mAb and SIC4.8R mAb was more
active in solution than bound to plastic. The F(ab’)78 GRIEBEL et al.
rabbit anti-sheep IgM (Cappel Laboratories, West
Chester, PA) was used at a final concentration of
40 tg/ml (Griebel et al., 1991). The recombinant
human IL-2, IL-4, IL-7, and IL-15 (Peprotech EC,
London) were used at a final concentration of
100 ng/ml and had specific cross-species activities
with iPfB cells (Griebel and Ferrari, manuscript sub-
mitted). The mCD40L/J558L cells were cocultured
with iPfB cells at a final ratio of 1:10 (mCD40L:iPfB
cells). IPfB cells were cultured at a density of 10 x
106 cells/well in 6-well plates and 4 x 105 cells/well
in 96-well plates. The murine pro-B cells were cul-
tured in 96-well plates at a density of 5 x 104 pro-B
cells with 1 x 104 ,-irradiated PA-6 cells/well and
10ng/ml recombinant human IL-7. Proliferative
response assays were conducted in quadruplicate
and incubated for 48 hr with 1 tCi [HB]-thymidine
(Amersham) added during the last 4 hr of culture.
The incorporation of [Hg]-thymidine was determined
using standard methods with a Betaplate 96-well
Harvester and Betamax liquid scintillation counter
(LKB Wallac, Turku, Finland).
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